Vlaykova T - Search Results

1

Enhanced expression of the tie receptor tyrosine kinase mesenger RNA in the vascular endothelium of metastatic melanomas.

Kaipainen A, Vlaykova T, Hatva E, Böhling T, Jekunen A, Pyrhönen S, Alitalo K. Kaipainen A, et al. Among authors: vlaykova t. Cancer Res. 1994 Dec 15;54(24):6571-7. Cancer Res. 1994. PMID: 7987857

2

Vascularity and prognosis of metastatic melanoma.

Vlaykova T, Muhonen T, Hahka-Kemppinen M, Pyrhönen S, Jekunen A. Vlaykova T, et al. Int J Cancer. 1997 Jun 20;74(3):326-9. doi: 10.1002/(sici)1097-0215(19970620)74:3<326::aid-ijc16>3.0.co;2-9. Int J Cancer. 1997. PMID: 9221813

3

Prognostic value of tumour vascularity in metastatic melanoma and association of blood vessel density with vascular endothelial growth factor expression.

Vlaykova T, Laurila P, Muhonen T, Hahka-Kemppinen M, Jekunen A, Alitalo K, Pyrhönen S. Vlaykova T, et al. Melanoma Res. 1999 Feb;9(1):59-68. doi: 10.1097/00008390-199902000-00008. Melanoma Res. 1999. PMID: 10338335

4

Prognostic value of tumour vascularity in primary melanoma.

Ilmonen S, Kariniemi AL, Vlaykova T, Muhonen T, Pyrhönen S, Asko-Seljavaara S. Ilmonen S, et al. Among authors: vlaykova t. Melanoma Res. 1999 Jun;9(3):273-8. doi: 10.1097/00008390-199906000-00009. Melanoma Res. 1999. PMID: 10465583

5

High expression levels of collagenase-1 and stromelysin-1 correlate with shorter disease-free survival in human metastatic melanoma.

Nikkola J, Vihinen P, Vlaykova T, Hahka-Kemppinen M, Kähäri VM, Pyrhönen S. Nikkola J, et al. Among authors: vlaykova t. Int J Cancer. 2002 Feb 1;97(4):432-8. doi: 10.1002/ijc.1636. Int J Cancer. 2002. PMID: 11802203 Clinical Trial.

6

Increased thymidylate synthase gene expression in metastatic melanoma.

Vlaykova T, Jekunen AP, Kesomaa M, Kairemo KJ, Pyrhönen S, Wasenius VM. Vlaykova T, et al. Oncology. 1997 Mar-Apr;54(2):146-52. doi: 10.1159/000227679. Oncology. 1997. PMID: 9075787

7

Analysis of G(1)/S checkpoint regulators in metastatic melanoma.

Sauroja I, Smeds J, Vlaykova T, Kumar R, Talve L, Hahka-Kemppinen M, Punnonen K, Jansèn CT, Hemminki K, Pyrhönen S. Sauroja I, et al. Among authors: vlaykova t. Genes Chromosomes Cancer. 2000 Aug;28(4):404-14. doi: 10.1002/1098-2264(200008)28:4<404::aid-gcc6>3.0.co;2-p. Genes Chromosomes Cancer. 2000. PMID: 10862049

8

Prognostic value of beta1 integrin expression in metastatic melanoma.

Vihinen P, Nikkola J, Vlaykova T, Hahka-Kemppinen M, Talve L, Heino J, Pyrhönen S. Vihinen P, et al. Among authors: vlaykova t. Melanoma Res. 2000 Jun;10(3):243-51. Melanoma Res. 2000. PMID: 10890378

9

Increased gene expression levels of collagen receptor integrins are associated with decreased survival parameters in patients with advanced melanoma.

Vuoristo M, Vihinen P, Vlaykova T, Nylund C, Heino J, Pyrhönen S. Vuoristo M, et al. Among authors: vlaykova t. Melanoma Res. 2007 Aug;17(4):215-23. doi: 10.1097/CMR.0b013e328270b935. Melanoma Res. 2007. PMID: 17625451 Clinical Trial.

10

High collagenase-1 expression correlates with a favourable chemoimmunotherapy response in human metastatic melanoma.

Nikkola J, Vihinen P, Vlaykova T, Hahka-Kemppinen M, Kähäri VM, Pyrhönen S. Nikkola J, et al. Among authors: vlaykova t. Melanoma Res. 2001 Apr;11(2):157-66. doi: 10.1097/00008390-200104000-00011. Melanoma Res. 2001. PMID: 11333126

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

64 results

Search Page

Filters